The Transition from Bronchopulmonary Dysplasia to Childhood Chronic Lung Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Pediatric Allergy, Immunology, and Pulmonology

• Publication date

  2011-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/ped.2011.0070PMID 35927857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of azithromycin for the prevention of bronchopulmonary dysplasia in preterm infants: a randomized, double‐blind, placebo controlled trial

  2011cited by this paper
• The new bronchopulmonary dysplasia

  2011cited by this paper
• Intercenter Differences in Bronchopulmonary Dysplasia or Death Among Very Low Birth Weight Infants

  2011cited by this paper
• Lung Function and Respiratory Symptoms at 11 Years in Children Born Extremely Preterm: The Epicure Study

  2011cited by this paper
• Oxygen and oxidative stress in bronchopulmonary dysplasia

  2010cited by this paper
• Recurrent wheezing in the third year of life among children born at 32 weeks' gestation or later: relationship to laboratory-confirmed, medically attended infection with respiratory syncytial virus during the first year of life.

  2010cited by this paper
• Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study.

  2010cited by this paper
• From BPD to COPD? The hypothesis is intriguing but we lack lung pathology data in humans

  2010cited by this paper
• Nature and severity of lung function abnormalities in extremely pre-term children at 11 years of age

  2010cited by this paper
• Mesenchymal stem cells in chronic lung disease: culprit or savior?

  2010cited by this paper
• Long-term azithromycin use in patients with chronic obstructive pulmonary disease and tracheostomy.

  2010cited by this paper
• Genetics of bronchopulmonary dysplasia in the age of genomics

  2010influential reference
• Pulmonary hypertension in chronic neonatal lung disease.

  2010cited by this paper
• Day Care Increases the Risk of Respiratory Morbidity in Chronic Lung Disease of Prematurity

  2010cited by this paper
• The EPICure study: maximal exercise and physical activity in school children born extremely preterm

  2009cited by this paper
• Prenatal inflammation and lung development.

  2009cited by this paper
• Particulate matter exposure in children: relevance to chronic obstructive pulmonary disease.

  2009cited by this paper
• Childhood asthma may be a consequence of vitamin D deficiency

  2009cited by this paper
• Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats.

  2009cited by this paper
• Models of Comprehensive Multidisciplinary Care for Individuals in the United States With Genetic Disorders

  2009cited by this paper
• A Review of the Evidence for the Medical Home for Children With Special Health Care Needs

  2009cited by this paper
• Nutrition and the Lung

  2009cited by this paper
• Role of macrolide therapy in chronic obstructive pulmonary disease

  2008cited by this paper
• A Review of the Evidence for the Medical Home for Children With Special Health Care Needs

  2008cited by this paper
• Impaired lung homeostasis in neonatal mice exposed to cigarette smoke.

  2008cited by this paper
• Chronic lung disease after premature birth.

  2008cited by this paper
• Reduced Exercise Capacity in Children Born Very Preterm

  2008cited by this paper
• Prematurity as a predictor of childhood asthma among low-income children.

  2008cited by this paper
• Neonatal hyperoxia enhances the inflammatory response in adult mice infected with influenza A virus.

  2008cited by this paper
• Detrimental effects of tobacco smoke exposure during development on postnatal lung function and asthma.

  2008cited by this paper
• Macrolides in cystic fibrosis.

  2007cited by this paper
• Pulmonary Artery Hypertension in Formerly Premature Infants With Bronchopulmonary Dysplasia: Clinical Features and Outcomes in the Surfactant Era

  2007cited by this paper
• Chronic lung disease after premature birth.

  2007cited by this paper
• Preterm delivery and asthma: a systematic review and meta-analysis.

  2006influential reference
• Contribution of inflammation to lung injury and development

  2006cited by this paper
• Summary Proceedings From the Bronchopulmonary Dysplasia Group

  2006cited by this paper
• Vascular Endothelial Growth Factor-A Induces Prenatal Neovascularization and Alters Bronchial Development in Mice

  2005cited by this paper
• Validation of the National Institutes of Health Consensus Definition of Bronchopulmonary Dysplasia

  2005cited by this paper
• Low exhaled nitric oxide in school-age children with bronchopulmonary dysplasia and airflow limitation.

  2005influential reference
• The effect of neonatal hyperoxia on the lung of p21Waf1/Cip1/Sdi1-deficient mice.

  2004cited by this paper
• Reduced Lung Cell Proliferation Following Short-Term Exposure to Ultrafine Soot and Iron Particles in Neonatal Rats: Key to Impaired Lung Growth?

  2004cited by this paper
• Palivizumab

  2004cited by this paper
• Association of Glutathione-S-Transferase-P1 (GST-P1) Polymorphisms with Bronchopulmonary Dysplasia

  2004cited by this paper
• Rhinovirus and the lower respiratory tract†

  2004influential reference
• Mechanisms and limits of induced postnatal lung growth.

  2004influential reference
• Viral Respiratory Infections in Children with Technology Dependence and Neuromuscular Disorders

  2004cited by this paper
• Respiratory outcome in school‐aged, very‐low‐birth‐weight children in the surfactant era

  2004cited by this paper
• The molecular genetics of lung morphogenesis and injury repair.

  2004cited by this paper
• Health and hospitalisations after discharge in extremely low birth weight infants

  2003cited by this paper
• Health and hospitalistions after discharge in extremely low birth weight infants.

  2003cited by this paper
• Rhinovirus et infections respiratoires aiguës de l’enfant hospitalisé. Étude rétrospective de 1998 à 2000

  2003cited by this paper
• Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure.

  2002cited by this paper
• Monitoring cardiovascular function in infants with chronic lung disease of prematurity

  2002cited by this paper
• Functional and pathological effects of prolonged hyperoxia in neonatal mice.

  1998cited by this paper
• Mechanisms initiating lung injury in the preterm.

  1998cited by this paper
• Induction of p21WAF/CIP1 during hyperoxia.

  1998cited by this paper
• Exercise ability in survivors of severe bronchopulmonary dysplasia.

  1997cited by this paper
• Rhinovirus infection associated with serious lower respiratory illness in patients with bronchopulmonary dysplasia.

  1997cited by this paper
• Bronchial lability and responsiveness in school children born very preterm.

  1997cited by this paper
• Consequences of hypogammaglobulinemia and steroid therapy in severe bronchopulmonary dysplasia

  1996influential reference
• Long‐term pulmonary functional outcome of bronchopulmonary dysplasia and premature birth

  1995cited by this paper
• Late pulmonary sequelae of bronchopulmonary dysplasia.

  1990cited by this paper
• Lung function eight years after neonatal ventilation.

  1989cited by this paper
• Antibody deficiency complicating severe bronchopulmonary dysplasia

  1989cited by this paper
• Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia.

  1987cited by this paper
• Postnatal human lung growth.

  1982cited by this paper
• Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia.

  1967cited by this paper

• Evolution of Lung Disease in the Premature Infant

  2011cites this paper